Robert Hagemann Net Worth

The estimated Net Worth of Robert Hagemann is at least $749 Tisíc dollars as of 28 August 2023. Mr. Hagemann owns over 2,000 units of Zimmer Biomet Inc stock worth over $420,600 and over the last 21 years he sold ZBH stock worth over $0. In addition, he makes $328,034 as Independent Director at Zimmer Biomet Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Hagemann ZBH stock SEC Form 4 insiders trading

Robert has made over 28 trades of the Zimmer Biomet Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 2,000 units of ZBH stock worth $232,960 on 28 August 2023.

The largest trade he's ever made was exercising 113,334 units of Zimmer Biomet Inc stock on 26 January 2012 worth over $5,920,568. On average, Robert trades about 2,228 units every 31 days since 2004. As of 28 August 2023 he still owns at least 4,000 units of Zimmer Biomet Inc stock.

You can see the complete history of Mr. Hagemann stock trades at the bottom of the page.

Robert Hagemann biography

Robert A. Hagemann is Independent Director of Zimmer Biomet Holdings, Inc. Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated until his retirement in July 2013. Mr. Hagemann joined Corning Life Sciences, Inc., a subsidiary of Quest Diagnostics’ former parent company, Corning Incorporated, in 1992, and held roles of increasing responsibility before being appointed Chief Financial Officer of Quest Diagnostics in 1998. Prior to joining Corning, Mr. Hagemann held senior financial positions at Prime Hospitality, Inc. and Crompton & Knowles, Inc. He was also previously employed by Arthur Young & Co., a predecessor company to Ernst & Young.

What is the salary of Robert Hagemann?

As the Independent Director of Zimmer Biomet Inc, the total compensation of Robert Hagemann at Zimmer Biomet Inc is $328,034. There are 11 executives at Zimmer Biomet Inc getting paid more, with Bryan Hanson having the highest compensation of $11,176,700.

How old is Robert Hagemann?

Robert Hagemann is 63, he's been the Independent Director of Zimmer Biomet Inc since 2008. There are 5 older and 17 younger executives at Zimmer Biomet Inc. The oldest executive at Zimmer Biomet Holdings Inc is Larry Glasscock, 72, who is the Independent Non-Executive Chairman of the Board.

What's Robert Hagemann's mailing address?

Robert's mailing address filed with the SEC is 345, East Main Street, Warsaw, Kosciusko County, Indiana, 46580, United States.

Insiders trading at Zimmer Biomet Inc

Over the last 9 years, insiders at Zimmer Biomet Inc have traded over $2,148,754,462 worth of Zimmer Biomet Inc stock and bought 59,988 units worth $7,136,091 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Michael W Michelson a Group Inc Blackstone Group .... On average, Zimmer Biomet Inc executives and independent directors trade stock every 19 days with the average trade being worth of $14,226,269. The most recent stock trade was executed by Zuilen Wilfred Van on 1 July 2024, trading 2,633 units of ZBH stock currently worth $276,860.

What does Zimmer Biomet Inc do?

zimmer biomet is the world’s most trusted brand for personalized bone and joint healthcare solutions. we help people discover and achieve exceptional outcomes. as a leading innovator in musculoskeletal healthcare, we offer a complete portfolio of products for joint reconstruction, bone and skeletal repair, sports medicine, spine, and dental reconstruction. every day, we focus on improving musculoskeletal healthcare. it’s all we do. it’s all we’ve ever done. for nearly 90 years, zimmer biomet has helped people progress beyond their pain and limitations. because it’s not just what we make, it’s what we make possible. zimmer biomet serves healthcare professionals and their patients globally. our worldwide headquarters is in warsaw, indiana, usa.

Complete history of Mr. Hagemann stock trades at Graphic Packaging Co, Quest Diagnostics, Ryder System a Zimmer Biomet Inc

Zimmer Biomet Inc executives and stock owners

Zimmer Biomet Inc executives and other stock owners filed with the SEC include:

• Bryan Hanson,
  President, Chief Executive Officer, Director
• Suketu Upadhyay,
  Chief Financial Officer, Executive Vice President
• Ivan Tornos,
  Group President - Global Businesses and Americas
• Didier Deltort,
  President - Europe, Middle East and Africa
• Bryan C. Hanson,
  Chairman, Pres & CEO
• Chad Phipps,
  Senior Vice President, General Counsel, Secretary
• Sang Yi,
  President, Asia Pacific
• Ivan Tornos,
  Group Pres of Global Bus.es, The Americas & EMEA Region and COO
• Suketu P. Upadhyay,
  Exec. VP & CFO
• Sang Yi,
  Group Pres of Asia Pacific
• Larry Glasscock,
  Independent Non-Executive Chairman of the Board
• Robert Hagemann,
  Independent Director
• Arthur Higgins,
  Independent Director
• Betsy Bernard,
  Independent Director
• Christopher Begley,
  Independent Director
• Gail Boudreaux,
  Independent Director
• Michael Farrell,
  Independent Director
• Michael Michelson,
  Independent Director
• Maria Hilado,
  Independent Director
• Syed Jafry,
  Independent Director
• Carrie Nichol,
  Chief Accounting Officer, Vice President, Controller
• Keri Mattox,
  Senior Vice President - Investor Relations, Chief Communications Officer
• Angela Main,
  Sr. VP, Global Chief Compliance Officer & Associate Gen. Counsel of Asia Pacific
• Chad F. Phipps,
  Sr. VP, Gen. Counsel & Sec.
• Zeeshan Tariq,
  Sr. VP & Chief Information Officer
• Dr. Nitin Goyal M.D.,
  Chief Science, Technology & Innovation Officer
• Derek M. Davis,
  Interim Controller, Chief Accounting Officer, & Principal Accounting Officer
• Louis Shapiro,
  Director
• David C Dvorak,
  President and CEO
• Paul Bisaro,
  Director
• David A. Jr. Nolan,
  Group President
• Adam Rudolph Johnson,
  Group President
• Cecil B Pickett,
  Director
• Katarzyna Mazur Hofsaess,
  Pres., Eur., M. East & Afr.
• Robert D. Delp,
  President, Americas
• Tony W. Collins,
  VP, Controller and CAO
• Jeffrey K. Rhodes,
  Director
• Daniel E. Williamson,
  Group President
• Zuilen Wilfred Van,
  Group Pres, EMEA
• Rachel Ellingson,
  SVP & Chief Strategy Officer
• Aure Bruneau,
  Group President
• Daniel P Florin,
  Exec. VP, CFO
• Sachs Group Incgoldman Sach...,
  
• Stuart G. Kleopfer,
  President, Americas
• Equity Partners 2004 Direct...,
  
• Group Holdings (Sbs) Adviso...,
  
• Group Inc Blackstone Group ...,
  
• Group L.P.Blackstone Manage...,
  
• Capital Partners V L P Blac...,
  
• Acquisition Holding, Llc Lvb,
  
• Sreelakshmi Kolli,
  Director
• Lori Winkler,
  SVP and CHRO
• Devdatt Kurdikar,
  Director
• Derek M Davis,
  Interim Controller & CAO
• Paul A Stellato,
  VP, Controller & CAO
• Mark Bezjak,
  President, Americas